Latest share price

AstraZeneca PLC

13 May 2026 14:58 PM

20 minutes delayed

Value/last trade

13,730.00 GBX

-0.13%

-18.00

Day high/low

13,814.00 - 13,584.00

Ex-Dividend Date

19 Feb 2026

Dividend Pay Date

23 Mar 2026

Rolling 12m Net Div

1.6

London Stock Exchange

AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Invest with Davy

Investing is in our DNA. Whatever your investment objectives, our dedicated wealth advisers can introduce you to a world of opportunity, curated by the Davy investment team.

Adviser-lead investing Self-directed investing

© Morningstar. All Rights Reserved. The information, data, analyses and opinions contained herein (1) include the confidential and proprietary information of Morningstar, and/or its content providers; (2) may include, or be derived from, account information provided by your financial advisor which cannot be verified by Morningstar; (3) may not be copied or redistributed; (4) do not constitute investment advice offered by Morningstar; (5) are provided solely for informational purposes and therefore are not an offer or recommendation to buy or sell a security; and (6) are not warranted to be correct, complete or accurate. Except as otherwise required by law, Morningstar shall not be responsible for any trading decisions, damages or other losses resulting from, or related to, this information, data, analyses or opinions or their use.

Warning: Past performance is not a reliable guide to future performance. The value of investments and of any income derived from them may go down as well as up. You may not get back all of your original investment. Returns on investments may increase or decrease as a result of currency fluctuations.